Cno Financial Group, Inc. CNO
We take great care to ensure that the data presented and summarized in this overview for CNO Financial Group, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CNO
View all-
Black Rock Inc. New York, NY14.7MShares$595 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.4MShares$543 Million0.01% of portfolio
-
State Street Corp Boston, MA4.87MShares$198 Million0.01% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA4.29MShares$174 Million0.62% of portfolio
-
Franklin Resources Inc San Mateo, CA4.14MShares$168 Million0.04% of portfolio
-
Lsv Asset Management Chicago, IL3.91MShares$159 Million0.34% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.65MShares$148 Million0.03% of portfolio
-
Richard Pzena Pzena Investment Management LLC3.18MShares$129 Million0.42% of portfolio
-
American Century Companies Inc Kansas City, MO2.69MShares$109 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C32.52MShares$102 Million0.11% of portfolio
Latest Institutional Activity in CNO
Top Purchases
Top Sells
About CNO
CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance, and other insurance products for senior and middle-income markets in the United States. It offers Medicare supplement, supplemental health, and long-term care insurance policies; life insurance; and annuities, as well as Medicare advantage plans to individuals through phone, online, mail, and face-to-face. The company also focuses on worksite and group sales for businesses, associations, and other membership groups by interacting with customers at their place of employment. In addition, it provides fixed index annuities; fixed interest annuities, including fixed rate single and flexible premium deferred annuities; single premium immediate annuities; supplemental health products, such as specified disease, accident, and hospital indemnity products; and long-term care plans primarily to retirees and older self-employed individuals in the middle-income market. Further, the company offers universal life and other interest-sensitive life products; and traditional life policies that include whole life, graded benefit life, term life, and single premium whole life products, as well as graded benefit life insurance products. CNO Financial Group, Inc. markets its products under the Bankers Life, Washington National, and Colonial Penn brand names. The company sells its products through agents, independent producers, and direct marketing. CNO Financial Group, Inc. was founded in 1979 and is headquartered in Carmel, Indiana.
Insider Transactions at CNO
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 21
2025
|
Matthew J. Zimpfer General Counsel |
SELL
Open market or private sale
|
Direct |
40,800
-16.66%
|
$1,632,000
$40.1 P/Share
|
Feb 19
2025
|
Matthew J. Zimpfer General Counsel |
SELL
Open market or private sale
|
Direct |
40,800
-14.28%
|
$1,672,800
$41.49 P/Share
|
Feb 11
2025
|
Matthew J. Zimpfer General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+4.67%
|
$518,000
$37.95 P/Share
|
Feb 11
2025
|
Matthew J. Zimpfer General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,978
-1.8%
|
$184,186
$37.95 P/Share
|
Feb 11
2025
|
Matthew J. Zimpfer General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
17,056
+5.81%
|
$631,072
$37.95 P/Share
|
Feb 11
2025
|
Michael E. Mead Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,200
+8.99%
|
$155,400
$37.95 P/Share
|
Feb 11
2025
|
Michael E. Mead Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,434
-3.61%
|
$53,058
$37.95 P/Share
|
Feb 11
2025
|
Michael E. Mead Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,221
+7.5%
|
$119,177
$37.95 P/Share
|
Feb 11
2025
|
Rocco F Tarasi Iii Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,600
+8.03%
|
$281,200
$37.95 P/Share
|
Feb 11
2025
|
Rocco F Tarasi Iii Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,936
-3.56%
|
$108,632
$37.95 P/Share
|
Feb 11
2025
|
Rocco F Tarasi Iii Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,476
+10.32%
|
$350,612
$37.95 P/Share
|
Feb 11
2025
|
Jeremy David Williams Chief Actuary |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+4.32%
|
$111,000
$37.95 P/Share
|
Feb 11
2025
|
Jeremy David Williams Chief Actuary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,137
-1.76%
|
$42,069
$37.95 P/Share
|
Feb 11
2025
|
Jeremy David Williams Chief Actuary |
BUY
Grant, award, or other acquisition
|
Direct |
3,798
+5.56%
|
$140,526
$37.95 P/Share
|
Feb 11
2025
|
Karen De Toro President, Worksite Division |
BUY
Grant, award, or other acquisition
|
Direct |
7,600
+9.5%
|
$281,200
$37.95 P/Share
|
Feb 11
2025
|
Karen De Toro President, Worksite Division |
SELL
Payment of exercise price or tax liability
|
Direct |
4,212
-6.1%
|
$155,844
$37.95 P/Share
|
Feb 11
2025
|
Karen De Toro President, Worksite Division |
BUY
Grant, award, or other acquisition
|
Direct |
9,476
+12.07%
|
$350,612
$37.95 P/Share
|
Feb 11
2025
|
Yvonne K Franzese Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,600
+18.52%
|
$392,200
$37.95 P/Share
|
Feb 11
2025
|
Yvonne K Franzese Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,813
-11.78%
|
$178,081
$37.95 P/Share
|
Feb 11
2025
|
Yvonne K Franzese Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,922
+24.03%
|
$478,114
$37.95 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 456K shares |
---|---|
Bona fide gift | 1.91K shares |
Exercise of conversion of derivative security | 63.6K shares |
Payment of exercise price or tax liability | 186K shares |
---|---|
Bona fide gift | 39.7K shares |
Open market or private sale | 369K shares |